Journal ArticleOPEN ACCESS

Patient-Centric Approaches for Phase I Combination Trials Come on Stage

Cancer Discovery (2023) 13(8) 1762-1764
DOI: 10.1158/2159-8290.CD-23-0534
4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Summary: A disruptive clinical trial design allowed Drilon and colleagues to demonstrate proof of concept of the potential of PF-07284892 to overcome resistance mechanisms to targeted therapies in the clinic.

Cite

CITATION STYLE

APA

Hernando-Calvo, A., & Garralda, E. (2023). Patient-Centric Approaches for Phase I Combination Trials Come on Stage. Cancer Discovery, 13(8), 1762–1764. https://doi.org/10.1158/2159-8290.CD-23-0534

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free